Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Pharmacogenetics of antidepressant drugs: current clinical practice and future directions.

Narasimhan S, Lohoff FW.

Pharmacogenomics. 2012 Mar;13(4):441-64. doi: 10.2217/pgs.12.1. Review.

PMID:
22380000
2.

Serotonin pathway polymorphisms and the treatment of major depressive disorder and anxiety disorders.

Helton SG, Lohoff FW.

Pharmacogenomics. 2015;16(5):541-53. doi: 10.2217/pgs.15.15. Review.

PMID:
25916524
3.

The role of pharmacogenetics in the treatment of depression and anxiety disorders.

Schosser A, Kasper S.

Int Clin Psychopharmacol. 2009 Nov;24(6):277-88. doi: 10.1097/YIC.0b013e3283306a2f. Review.

PMID:
19738481
4.

Pharmacogenomics of antidepressant drugs.

Horstmann S, Binder EB.

Pharmacol Ther. 2009 Oct;124(1):57-73. doi: 10.1016/j.pharmthera.2009.06.007. Epub 2009 Jun 27. Review.

PMID:
19563827
5.

Pharmacogenomics and antidepressant drugs.

Binder EB, Holsboer F.

Ann Med. 2006;38(2):82-94. Review.

PMID:
16581694
6.

From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment.

Fabbri C, Porcelli S, Serretti A.

Can J Psychiatry. 2014 Feb;59(2):62-75. Review.

7.

Pharmacogenetics of antidepressant response.

Porcelli S, Drago A, Fabbri C, Gibiino S, Calati R, Serretti A.

J Psychiatry Neurosci. 2011 Mar;36(2):87-113. doi: 10.1503/jpn.100059. Review.

8.

[Pharmacogenetics and anxiety disorders: analysis of recent findings].

Amitai M, Kronenberg S, Cohen T, Frisch A, Weizman A, Apter A.

Harefuah. 2014 Mar-Apr;153(3-4):210-4, 236. Review. Hebrew.

PMID:
24791568
9.

Pharmacogenetics of antidepressant response.

Keers R, Aitchison KJ.

Expert Rev Neurother. 2011 Jan;11(1):101-25. doi: 10.1586/ern.10.186. Review.

PMID:
21158559
10.
11.
12.

Genome-wide association studies in pharmacogenomics of antidepressants.

Lin E, Lane HY.

Pharmacogenomics. 2015;16(5):555-66. doi: 10.2217/pgs.15.5. Review.

PMID:
25916525
13.

Pharmacogenetics in the treatment of depression: pharmacodynamic studies.

Serretti A, Artioli P, Quartesan R.

Pharmacogenet Genomics. 2005 Feb;15(2):61-7. Review.

PMID:
15861029
14.

Genetics and personalized medicine in antidepressant treatment.

Gvozdic K, Brandl EJ, Taylor DL, Müller DJ.

Curr Pharm Des. 2012;18(36):5853-78. Review.

PMID:
22681166
15.

[Pharmacogenetics of depression in elderly patients].

Monnin J, Haffen E, Sechter D, Vandel P.

Psychol Neuropsychiatr Vieil. 2009 Mar;7(1):43-55. doi: 10.1684/pnv.2009.0157. Review. French.

16.

Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research.

Fabbri C, Di Girolamo G, Serretti A.

Am J Med Genet B Neuropsychiatr Genet. 2013 Sep;162B(6):487-520. doi: 10.1002/ajmg.b.32184. Epub 2013 Jul 12. Review.

PMID:
23852853
17.

Value of genetic and epigenetic testing as biomarkers of response to antidepressant treatment.

Frieling H, Tadić A.

Int Rev Psychiatry. 2013 Oct;25(5):572-8. doi: 10.3109/09540261.2013.816657. Review.

PMID:
24151802
18.

The influence of ethnicity and antidepressant pharmacogenetics in the treatment of depression.

Jann MW, Cohen LJ.

Drug Metabol Drug Interact. 2000;16(1):39-67. Review.

PMID:
10820582
19.

[Coadministration benzodiazepine and antidepressant drugs: the state of art].

Martin P.

Encephale. 2006 Oct;32(5 Pt 1):753-66. Review. French.

PMID:
17099600
20.

Pharmacogenetic insights into depression and antidepressant response: does sex matter?

Pitychoutis PM, Zisaki A, Dalla C, Papadopoulou-Daifoti Z.

Curr Pharm Des. 2010;16(20):2214-23. Review.

PMID:
20459391

Supplemental Content

Support Center